Sherlock Biosciences
Business Services · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
200 Talcott Ave, Watertown, Massachusett...Phone Number
(617) 612-8209Website
sherlock.bioRevenue
$12.7 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
2
2
1
1
1
About Sherlock Biosciences
Sherlock Biosciences is dedicated to making molecular diagnostics better, faster and more affordable through Engineering Biology platforms. The company is developing applications of SHERLOCK, a CRISPR-based method to detect and quantify specific genetic sequences, and INSPECTRTM, a Synthetic Biology-based molecular diagnostics platform that is instrument-free. SHERLOCK and INSPECTR can be used in virtually any setting without complex instrumentation, opening up a wide range of potential applications in areas including precision oncology, infection identification, food safety, at-home tests and disease detection in the field. In May 2020, the company received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Sherlock CRISPR SARS-CoV-2 kit, the first FDA-authorized use of CRISPR technology.Explore more
Sherlock Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sherlock Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Sherlock Biosciences
Product Launch: Get notified when Sherlock Biosciences launches new products
Click to see if Sherlock Biosciences had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Sherlock Biosciences has new funding data
Check out if Sherlock Biosciences is spiking on competitors!
Sherlock Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Sherlock Biosciences recently announced quarterly report
Check if Sherlock Biosciences has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Sherlock Biosciences
Compare insights from companies similar to Sherlock Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sherlock Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Sherlock Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Sherlock Biosciences.
Sherlock Biosciences financials insights
Gather financial insights about Sherlock Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Grant
$2M
2022
Series B
$80M
Sherlock Biosciences Tech Stack
A closer look at the technologies used by Sherlock Biosciences
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
Left Company
Executive Move
Executive Moves, Left Company
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Funding
Project
Engineering, Security, Bioengineering
Executive Move
Sherlock Biosciences News & Media
OraSure Technologies Acquires Sherlock Biosciences
OraSure Technologies Acquires Sherlock BiosciencesSherlock Biosciences licenses Wyss Institute’s ambient nucleic acid amplification technology from Harvard to develop highly accurate, low-cost diagnostics for point-of-need
The method, integrated with highly specific CRISPR-based nucleic acid detection technology, could enable simple-to-use, portable and ultra-sensitive diagnostics for infectious disease detection in low-resource settings The method, integrated with highly specific CRISPR-based nucleic acid detection technology, could enable simple-to-use, portable and ultra-sensitive diagnostics for infectious disease detection in low-resource settingsSherlock Biosciences Appoints Karen Davies as Chief Development Officer
Company Expands Leadership Team on Heels of Recent $80 Million Series B Financing BOSTON, April 7, 2022 /PRNewswire/ -- Sherlock Biosciences, a company engineering biology to bring next-generation diagnostics to the point-of-need, today announced that industry veteran Karen Davies has...
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Sherlock Biosciences
Sign Up For FreeTo access detailed company insights
Sherlock Biosciences is dedicated to making molecular diagnostics better, faster and more affordable through Engineering Biology platforms. The company is developing applications of SHERLOCK, a CRISPR-based method to detect and quantify specific genetic sequences, and INSPECTRTM, a Synthetic Biology-based molecular diagnostics platform that is inst... Read More
